Pediatric Metastatic Crohn's Disease
Autor: | Ilson Geraldo da Silva, Amanda Trindade de Oliveira, Matheus Matta Machado Mafra Duque Estrada Meyer, Raissa Albuquerque Calais de Oliveira, Matheus Duarte Massahud |
---|---|
Rok vydání: | 2021 |
Předmět: |
Gastrointestinal tract
medicine.medical_specialty Crohn's disease business.industry Gastroenterology Disease Anus medicine.disease Dermatology Infliximab Vulva 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Ustekinumab Adalimumab medicine 030211 gastroenterology & hepatology business medicine.drug |
Zdroj: | Journal of Coloproctology. 41:079-082 |
ISSN: | 2317-6423 2237-9363 |
DOI: | 10.1055/s-0041-1724066 |
Popis: | Crohn's disease (CD) is a chronic, relapsing, idiopathic condition, characterized by granulomatous, transmural inflammation of the gastrointestinal tract, which can affect its entire length, from mouth to anus. Metastatic Crohn's disease (MCD) is a rare form of skin involvement and is defined by skin lesions without contiguity with the gastrointestinal tract. A 9-year-old patient presented with gastrointestinal complaints and gross skin lesions in the vulva and perianal region. The diagnosis of Crohn's disease was made when the patient was 11 years old, after being evaluated by the colorectal surgeon. Treatment was started with a “top-down” approach, with a sustained response for four years. Afterwards, there was a relapse of the skin disease in previously normal areas, without overt symptoms. Treatment consisted of steroids and local infiltration of infliximab, without improvement. A year later, there was a rapid progression of the skin lesions, and the drug changed to adalimumab, also without response and worsening of the skin lesions. The patient was admitted to the hospital and intravenous steroids were initiated, along with surgical debridement of the lesions. After some improvement, ustekinumab was initiated with satisfactory response. Pediatric MCD has an important impact on the patient's quality of life, with influences on growth and social development. |
Databáze: | OpenAIRE |
Externí odkaz: |